Market Cap 2.98B
Revenue (ttm) 125.60M
Net Income (ttm) -2.03B
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -1,613.86%
Debt to Equity Ratio 0.00
Volume 1,030,300
Avg Vol 974,308
Day's Range N/A - N/A
Shares Out 36.05M
Stochastic %K 64%
Beta 4.11
Analysts Sell
Price Target $61.50

Company Profile

GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing,...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 833 694 2553
Website: grail.com
Address:
1525 O’Brien Drive, Menlo Park, United States
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 25 at 3:56 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $GRAL Current Share Price: $81.70 Contracts: $GRAL January 15, 2027 $85 Calls Scale in: $24.93- $30.47 Scale out: $38.78-$49.86 Can Easily Capture: 60% ROI Blended DTE: 449 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
CapitalGains007
CapitalGains007 Oct. 24 at 6:08 PM
$GRAL belongs in the $5-8/share range
1 · Reply
BringDownThoseReps
BringDownThoseReps Oct. 24 at 4:04 PM
$GRAL this guy LOL, it never stops being constant entertainment
0 · Reply
oneyedjacks
oneyedjacks Oct. 24 at 3:35 PM
$GRAL $3B MC but $8B buyout was denied.... $MNKD Both of these have huge TAM with unmet needs
0 · Reply
sogenerous
sogenerous Oct. 24 at 3:28 PM
$GRAL was so nice 77s for quick trade - was going to post but felt stronger on NBIS IONQ BE
0 · Reply
Quantcompass
Quantcompass Oct. 24 at 1:54 PM
$HIMS The investment in $GRAL should be looked far beyond the investment itself. Its a testament of the company’s strategic long term vision. Shorting hims by any particular reason or vertical will become a worse idea with each passing day.
0 · Reply
Parnell8
Parnell8 Oct. 23 at 5:27 PM
$GRAL it all sounds so good. Where’s tumor origin? Dx odyssey? Mced act enactment isn’t gonna happen we can’t afford it with the specificity and sensitivity of this assay at $5-1k
0 · Reply
jamItIn91
jamItIn91 Oct. 23 at 4:25 PM
$GRAL “Galleri (Grail's test) is the only available MCED test with demonstrated performance in an intended use population being screened for cancer. These new data build on the results from our first clinical implementation study, PATHFINDER, which was published in the Lancet in 2023, and showed that Galleri approximately DOUBLED THE NUMBER OF CANCERS IDENTIFIED when added to standard of care screening,” said Josh Ofman, MD, MSHS, President of GRAIL. “We’re witnessing the beginning of a transformative era for cancer screening, with these results demonstrating Galleri’s ability to detect cancers earlier, when they can be easier to treat and are potentially curable.”
0 · Reply
Aquarian
Aquarian Oct. 23 at 3:32 PM
$HIMS The $325M investment in $GRAL will pay off nicely next year.
0 · Reply
angelinvesting369
angelinvesting369 Oct. 23 at 12:35 PM
$TSLA Like Tesla $ILMN Illumina has done some amazing things. They created gene sequencing. They also created $GRAL . Their only mistake was spinning Grail off. The reason they paid so much $8B in their failed attempt to buy Grail back is they knew Grail has an almost infinite TAM. https://youtu.be/j16zw6v5nQ4?si=LYINZL6MX4A49J2X
0 · Reply
Latest News on GRAL
What's Happening With GRAIL Stock?

Oct 17, 2025, 9:55 AM EDT - 8 days ago

What's Happening With GRAIL Stock?


Grail: A Speculative Buy

Sep 30, 2025, 12:17 PM EDT - 25 days ago

Grail: A Speculative Buy


mRNA Biotechs - Long-Term Value Risks Abound

Aug 28, 2025, 6:20 AM EDT - 2 months ago

mRNA Biotechs - Long-Term Value Risks Abound

ALNY BNTX DHR ILMN IONS MRNA RGEN


GRAIL, Inc. (GRAL) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 7:13 PM EDT - 2 months ago

GRAIL, Inc. (GRAL) Q2 2025 Earnings Call Transcript


GRAIL Reports Second Quarter 2025 Financial Results

Aug 12, 2025, 4:02 PM EDT - 2 months ago

GRAIL Reports Second Quarter 2025 Financial Results


GRAIL to Announce Second Quarter 2025 Financial Results

Jul 29, 2025, 4:02 PM EDT - 3 months ago

GRAIL to Announce Second Quarter 2025 Financial Results


The Holy Grail of Automation: Now a Robot Can Unload a Truck

Jun 23, 2025, 5:30 AM EDT - 4 months ago

The Holy Grail of Automation: Now a Robot Can Unload a Truck


Grail Shares Jump on Promising Results for Galleri Study

Jun 18, 2025, 12:43 PM EDT - 4 months ago

Grail Shares Jump on Promising Results for Galleri Study


GRAIL to Present at Jefferies Global Healthcare Conference 2025

May 21, 2025, 4:05 PM EDT - 5 months ago

GRAIL to Present at Jefferies Global Healthcare Conference 2025


GRAIL, Inc. (GRAL) Q1 2025 Earnings Call Transcript

May 13, 2025, 7:16 PM EDT - 5 months ago

GRAIL, Inc. (GRAL) Q1 2025 Earnings Call Transcript


GRAIL Reports First Quarter 2025 Financial Results

May 13, 2025, 4:01 PM EDT - 5 months ago

GRAIL Reports First Quarter 2025 Financial Results


GRAIL to Announce First Quarter 2025 Financial Results

Apr 29, 2025, 4:01 PM EDT - 6 months ago

GRAIL to Announce First Quarter 2025 Financial Results


GRAIL's Galleri Progresses While Back In Accumulation Levels

Apr 12, 2025, 9:32 AM EDT - 7 months ago

GRAIL's Galleri Progresses While Back In Accumulation Levels


How Does GRAIL Benefit From The Proposed MCED Legislation?

Apr 8, 2025, 9:49 AM EDT - 7 months ago

How Does GRAIL Benefit From The Proposed MCED Legislation?


GRAIL to Present at TD Cowen 45th Annual Health Care Conference

Feb 21, 2025, 9:00 AM EST - 8 months ago

GRAIL to Present at TD Cowen 45th Annual Health Care Conference


GRAIL, Inc. (GRAL) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 10:09 PM EST - 8 months ago

GRAIL, Inc. (GRAL) Q4 2024 Earnings Call Transcript


GRAIL to Announce Fourth Quarter 2024 Financial Results

Feb 12, 2025, 4:02 PM EST - 9 months ago

GRAIL to Announce Fourth Quarter 2024 Financial Results


GRAIL to Participate in Upcoming Investor Conferences

Nov 19, 2024, 4:05 PM EST - 1 year ago

GRAIL to Participate in Upcoming Investor Conferences


GRAIL Inc. (GRAL) Q3 2024 Earnings Call Transcript

Nov 15, 2024, 4:18 AM EST - 1 year ago

GRAIL Inc. (GRAL) Q3 2024 Earnings Call Transcript


GRAIL Reports Third Quarter 2024 Financial Results

Nov 12, 2024, 4:06 PM EST - 1 year ago

GRAIL Reports Third Quarter 2024 Financial Results


GRAIL to Announce Third Quarter 2024 Financial Results

Oct 29, 2024, 4:01 PM EDT - 1 year ago

GRAIL to Announce Third Quarter 2024 Financial Results


LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 25 at 3:56 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $GRAL Current Share Price: $81.70 Contracts: $GRAL January 15, 2027 $85 Calls Scale in: $24.93- $30.47 Scale out: $38.78-$49.86 Can Easily Capture: 60% ROI Blended DTE: 449 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
CapitalGains007
CapitalGains007 Oct. 24 at 6:08 PM
$GRAL belongs in the $5-8/share range
1 · Reply
BringDownThoseReps
BringDownThoseReps Oct. 24 at 4:04 PM
$GRAL this guy LOL, it never stops being constant entertainment
0 · Reply
oneyedjacks
oneyedjacks Oct. 24 at 3:35 PM
$GRAL $3B MC but $8B buyout was denied.... $MNKD Both of these have huge TAM with unmet needs
0 · Reply
sogenerous
sogenerous Oct. 24 at 3:28 PM
$GRAL was so nice 77s for quick trade - was going to post but felt stronger on NBIS IONQ BE
0 · Reply
Quantcompass
Quantcompass Oct. 24 at 1:54 PM
$HIMS The investment in $GRAL should be looked far beyond the investment itself. Its a testament of the company’s strategic long term vision. Shorting hims by any particular reason or vertical will become a worse idea with each passing day.
0 · Reply
Parnell8
Parnell8 Oct. 23 at 5:27 PM
$GRAL it all sounds so good. Where’s tumor origin? Dx odyssey? Mced act enactment isn’t gonna happen we can’t afford it with the specificity and sensitivity of this assay at $5-1k
0 · Reply
jamItIn91
jamItIn91 Oct. 23 at 4:25 PM
$GRAL “Galleri (Grail's test) is the only available MCED test with demonstrated performance in an intended use population being screened for cancer. These new data build on the results from our first clinical implementation study, PATHFINDER, which was published in the Lancet in 2023, and showed that Galleri approximately DOUBLED THE NUMBER OF CANCERS IDENTIFIED when added to standard of care screening,” said Josh Ofman, MD, MSHS, President of GRAIL. “We’re witnessing the beginning of a transformative era for cancer screening, with these results demonstrating Galleri’s ability to detect cancers earlier, when they can be easier to treat and are potentially curable.”
0 · Reply
Aquarian
Aquarian Oct. 23 at 3:32 PM
$HIMS The $325M investment in $GRAL will pay off nicely next year.
0 · Reply
angelinvesting369
angelinvesting369 Oct. 23 at 12:35 PM
$TSLA Like Tesla $ILMN Illumina has done some amazing things. They created gene sequencing. They also created $GRAL . Their only mistake was spinning Grail off. The reason they paid so much $8B in their failed attempt to buy Grail back is they knew Grail has an almost infinite TAM. https://youtu.be/j16zw6v5nQ4?si=LYINZL6MX4A49J2X
0 · Reply
SM07
SM07 Oct. 22 at 3:25 PM
$GRAL No reason really for the SP to stay above $70 whilst the new money is locking in huge gains
0 · Reply
MrMagician
MrMagician Oct. 22 at 2:54 PM
$GRAL if this is $ 80/sh without FDA approval and without SEA sales... wait til 2027. Buy and DCA or just buy LEAP option calls on the cheap.
0 · Reply
healthcareguru
healthcareguru Oct. 22 at 2:43 PM
$GRAL 😂😂😂😂😂😂😂😂😂😂😂😂
0 · Reply
JarvisFlow
JarvisFlow Oct. 22 at 1:55 PM
Canaccord Genuity updates rating for GRAIL ( $GRAL ) to Buy, target set at 75 → 85.
0 · Reply
Frito1856
Frito1856 Oct. 22 at 4:19 AM
$GRAL mentioned on Cramer during lightning round.
2 · Reply
angelinvesting369
angelinvesting369 Oct. 21 at 10:50 PM
$GRAL What makes 🍎 $AAPL 1. Every adult on 🌎 should use it 2. Need a new one every year
0 · Reply
angelinvesting369
angelinvesting369 Oct. 21 at 8:36 PM
$GRAL $HIMS $ISRG Da Vinci been around long before Optimus was a twinkle in it's Daddy's eye
0 · Reply
angelinvesting369
angelinvesting369 Oct. 21 at 8:18 PM
$GRAL Only thing as good as both Samsung and $HIMS investing in Grail would have been investment from$ISRG https://www.koreaherald.com/article/10595748
0 · Reply
angelinvesting369
angelinvesting369 Oct. 21 at 7:40 PM
$HIMS $GRAL mr mkt is badly missing the significance of Hims taking GRAIL to the masses
0 · Reply
angelinvesting369
angelinvesting369 Oct. 21 at 5:08 PM
$HIMS $GRAL https://www.dallasnews.com/sports/cowboys/2024/11/27/tad-carper-dallas-cowboys-cancer-dak-prescott-foundation/
0 · Reply
angelinvesting369
angelinvesting369 Oct. 21 at 4:50 PM
$GRAL $HIMS Grail has a $1T TAM https://x.com/himshouse/status/1980302234526331093?t=YR92hTRChSlN0eJsShNLVQ&s=19
0 · Reply
angelinvesting369
angelinvesting369 Oct. 21 at 4:46 PM
$GRAL $HIMS the mkt is badly missing the significance of this https://www.streetinsider.com/dr/news.php?id=25475488&gfv=1
1 · Reply